ASSOCIATION OF ELONGATION FACTORS AND ANTIBIOTICS WITH THE RIBOSOME
延伸因子和抗生素与核糖体的关联
基本信息
- 批准号:7173057
- 负责人:
- 金额:$ 3.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-12-01 至 2009-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAminoglycoside AntibioticsAntibioticsAntibodiesBacteriaBindingBinding SitesBiological ProcessBiologyBiopolymersCaliforniaCentrifugationChargeChromosome PairingComplexComputersCytoskeletal ProteinsDiffuseDiffusionDiseaseEEF1A1 geneElectrostaticsElongation FactorEnzyme KineticsEnzymesEventGene ExpressionGeneticGenetic CodeGenetic TranscriptionGenomeGoalsGrantImmuneImmune responseInternationalKineticsKnowledgeLettersLigandsMacromolecular ComplexesMeasuresMembraneMembrane ProteinsMessenger RNAMetabolismMethodsModelingModificationMolecularMotionMutationNamesNervous System PhysiologyNeurotransmittersNucleic AcidsNumbersObject AttachmentOrganismPeptide Elongation Factor GPeptide Elongation Factor TuPeptidesPlayPliabilityPolandProcessPropertyProteinsRangeRateReactionRelative (related person)ResearchRibonucleoproteinsRibosomesRoleSignal TransductionSolventsSynapsesSystemTechniquesThermodynamicsTimeTransfer RNATranslationsUniversitiesWorkbasedesignhuman EEF1A1 proteinmacromolecular assemblymolecular dynamicsmutantnovelparent grantparticlepreventreceptorresearch studysimulationsizetool
项目摘要
DESCRIPTION (provided by applicant): The main objective of this project is to determine the kinetics and energetics of binding of various ligands to the ribosome. These ligands include aminoglycoside antibiotics and their derivatives, elongation factors EF-Tu and EF-G and their proposed mutants. Timely and specific binding of these molecules is essential for the proper peptide formation in translation of the genetic code. EF-Tu and EF-G are crucial for, respectively, incorporating the aminoacylated tRNAs into the ribosome and for translocating both the tRNAs and mRNA after the peptide bond formation. Many antibiotics interfere with the binding of elongation factors, hinder the incorporation of the aminoacylated tRNA or inhibit functional conformational changes of the ribosome. The knowledge of what interactions govern the ligand encounter and binding with the ribosome will aid our understanding of the bi-molecular association, translation and inhibitory properties of antibiotics. The research will allow to propose experiments involving mutations of residues that prevent elongation factor binding and experiments suggesting derivatives of antibiotics that make their binding more specific. The effect of flexibility of ligands and the ribosome on association will be assessed. The techniques to study the energetics, thermodynamics, and kinetics of binding will include: molecular dynamics, Brownian dynamics and Poisson-Boltzmann implicit solvent models. Current simulation techniques will be extended and modified in order to enable the detailed studies of large macromolecular assemblies with over 200,000 atoms. The influence of long-range electrostatic steering will be investigated. The electrostatic similarity among the diffusing factors and complementarity with the ribosome binding site will be analyzed. The effect of flexibility of ligands and the ribosome on association will be assessed and the simulation methods will be extended to account for internal motions of the diffusing molecules. The project will promote international collaborative research between University of California at San Diego and Warsaw University in Poland. Blocking the ribosome function is important in curing many diseases, therefore, predictions of new molecules interfering with the ribosome are needed and this project will help to suggest them. The understanding of the mechanism governing the diffusion of molecules toward the ribosome could help in proposing novel antibiotics that bind stronger. This project will also help propose modifications of ribosome factors which hinder their correct association with the ribosome and prevent proper ribosome function.
描述(由申请人提供):本项目的主要目的是确定各种配体与核糖体结合的动力学和能量学。这些配体包括氨基糖苷类抗生素及其衍生物,延伸因子EF-Tu和EF-G及其拟议的突变体。这些分子的及时和特异性结合对于遗传密码翻译中的适当肽形成至关重要。EF-Tu和EF-G分别对于将氨酰化的tRNA整合到核糖体中以及在肽键形成后转运tRNA和mRNA至关重要。许多抗生素干扰延伸因子的结合,阻碍氨酰化tRNA的掺入或抑制核糖体的功能构象变化。什么样的相互作用支配配体的遭遇和与核糖体的结合的知识将有助于我们理解抗生素的双分子缔合,翻译和抑制特性。该研究将允许提出涉及阻止延伸因子结合的残基突变的实验,以及建议抗生素衍生物使其结合更特异性的实验。将评估配体和核糖体的柔性对缔合的影响。研究结合的能量学、热力学和动力学的技术包括:分子动力学、布朗动力学和泊松-玻尔兹曼隐式溶剂模型。目前的模拟技术将得到扩展和修改,以便能够详细研究超过20万个原子的大分子组装体。将研究远程静电转向的影响。将分析扩散因子之间的静电相似性和与核糖体结合位点的互补性。的配体和核糖体的灵活性对协会的影响将进行评估和模拟方法将扩展到考虑扩散分子的内部运动。该项目将促进圣地亚哥的加州大学和波兰的华沙大学之间的国际合作研究。阻断核糖体功能在治疗许多疾病中很重要,因此,需要预测干扰核糖体的新分子,该项目将有助于提出它们。对控制分子向核糖体扩散的机制的理解有助于提出结合更强的新型抗生素。该项目还将有助于提出核糖体因子的修饰,这些修饰阻碍了它们与核糖体的正确结合并阻止了核糖体的正常功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES ANDREW MCCAMMON其他文献
JAMES ANDREW MCCAMMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES ANDREW MCCAMMON', 18)}}的其他基金
BUILDING COMPLEXITY INTO THE COMPUTER-AIDED DRUG DESIGN PIPELINE THROUGH
通过增加计算机辅助药物设计流程的复杂性
- 批准号:
8362794 - 财政年份:2011
- 资助金额:
$ 3.54万 - 项目类别:
MOLECULAR FLEXIBILITY IN DRUG DESIGN USING MICROSECOND MOLECULAR DYNAMICS
利用微秒分子动力学的药物设计中的分子灵活性
- 批准号:
8364206 - 财政年份:2011
- 资助金额:
$ 3.54万 - 项目类别:
TOWARD DEVELOPING NEW ANTIVIRALS AGAINST AVIAN INFLUENZA MEMBRANE GLYCOPROTEINS
致力于开发针对禽流感膜糖蛋白的新型抗病毒药物
- 批准号:
8362795 - 财政年份:2011
- 资助金额:
$ 3.54万 - 项目类别:
MOD THE STRUCT & DYN OF NICOTINIC ACETYLCHOLINE RECEPTORS:
修改结构
- 批准号:
8362793 - 财政年份:2011
- 资助金额:
$ 3.54万 - 项目类别:
INTEGRATIVE MODEL OF SUBCELL PROCESSES: APPL TO SYNAPTIC ACT & PHARM DISCOVERY
子细胞过程的整合模型:应用于突触行为
- 批准号:
7955219 - 财政年份:2009
- 资助金额:
$ 3.54万 - 项目类别:
INTEGRATIVE MODEL OF SUBCELL PROCESSES: APPL TO SYNAPTIC ACT & PHARM DISCOVERY
子细胞过程的整合模型:应用于突触行为
- 批准号:
7722292 - 财政年份:2008
- 资助金额:
$ 3.54万 - 项目类别:
INTEGRATIVE MODEL OF SUBCELL PROCESSES: APPL TO SYNAPTIC ACT & PHARM DISCOVERY
子细胞过程的整合模型:应用于突触行为
- 批准号:
7601639 - 财政年份:2007
- 资助金额:
$ 3.54万 - 项目类别:
ASSOCIATION OF ELONGATION FACTORS AND ANTIBIOTICS WITH THE RIBOSOME
延伸因子和抗生素与核糖体的关联
- 批准号:
7537241 - 财政年份:2006
- 资助金额:
$ 3.54万 - 项目类别:
相似海外基金
Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
- 批准号:
10653587 - 财政年份:2023
- 资助金额:
$ 3.54万 - 项目类别:
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
- 批准号:
10585038 - 财政年份:2023
- 资助金额:
$ 3.54万 - 项目类别:
Creation of Next-generation Aminoglycoside Antibiotics Active against Multidrug-resistant Gram-negative Bacteria
开发对多重耐药革兰氏阴性菌具有活性的下一代氨基糖苷类抗生素
- 批准号:
20K06982 - 财政年份:2020
- 资助金额:
$ 3.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug- Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
- 批准号:
9934590 - 财政年份:2019
- 资助金额:
$ 3.54万 - 项目类别:
Combating Antibiotic Resistance to Aminoglycoside Antibiotics through Chemical Synthesis
通过化学合成对抗氨基糖苷类抗生素的耐药性
- 批准号:
392481159 - 财政年份:2017
- 资助金额:
$ 3.54万 - 项目类别:
Research Fellowships
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
- 批准号:
9082038 - 财政年份:2016
- 资助金额:
$ 3.54万 - 项目类别:
Functional analysis of radical SAM enzymes involved in the biosynthesis of aminoglycoside antibiotics
氨基糖苷类抗生素生物合成中自由基SAM酶的功能分析
- 批准号:
26410174 - 财政年份:2014
- 资助金额:
$ 3.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EAPSI:Synthesis of Aminoglycoside Antibiotics
EAPSI:氨基糖苷类抗生素的合成
- 批准号:
1106886 - 财政年份:2011
- 资助金额:
$ 3.54万 - 项目类别:
Fellowship Award
Preclinical evaluation of aminoglycoside antibiotics-derived amphiphiles (AADAs)
氨基糖苷类抗生素衍生的两亲物 (AADA) 的临床前评估
- 批准号:
185482 - 财政年份:2009
- 资助金额:
$ 3.54万 - 项目类别:
Operating Grants
AMINOGLYCOSIDE ANTIBIOTICS FOR CYSTIC FIBROSIS
治疗囊性纤维化的氨基糖苷类抗生素
- 批准号:
6565399 - 财政年份:2001
- 资助金额:
$ 3.54万 - 项目类别: